Although MYC amplification is rare in neuroblastoma, high c-MYC protein in patients with undifferentiated tumors was as frequent as 11% at diagnosis, suggesting that MYC transcriptional activation rather than gene amplification is a driver of aggressive tumor behavior in most c-MYC-driven neuroblastomas. Here, MYC is linked to neuroblastoma.